BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38347241)

  • 1. Nupr1-mediated vascular smooth muscle cell phenotype transformation involved in methamphetamine induces pulmonary hypertension.
    Zhou J; Guo D; Xu ZZ; Liao JS; Li XT; Duan K; Chen SY; Xie WB
    Cell Biol Toxicol; 2024 Feb; 40(1):13. PubMed ID: 38347241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.
    Wang Z; Yang K; Zheng Q; Zhang C; Tang H; Babicheva A; Jiang Q; Li M; Chen Y; Carr SG; Wu K; Zhang Q; Balistrieri A; Wang C; Song S; Ayon RJ; Desai AA; Black SM; Garcia JGN; Makino A; Yuan JX; Lu W; Wang J
    Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L216-L228. PubMed ID: 30358436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.
    Dai J; Zhou Q; Tang H; Chen T; Li J; Raychaudhuri P; Yuan JX; Zhou G
    Cell Signal; 2018 Nov; 51():119-129. PubMed ID: 30092353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic exposure to cigarette smoke on canonical transient receptor potential expression in rat pulmonary arterial smooth muscle.
    Wang J; Chen Y; Lin C; Jia J; Tian L; Yang K; Zhao L; Lai N; Jiang Q; Sun Y; Zhong N; Ran P; Lu W
    Am J Physiol Cell Physiol; 2014 Feb; 306(4):C364-73. PubMed ID: 24336649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated expression of STIM2, TRPC6, and Orai2 contributes to the transition of pulmonary arterial smooth muscle cells from a contractile to proliferative phenotype.
    Fernandez RA; Wan J; Song S; Smith KA; Gu Y; Tauseef M; Tang H; Makino A; Mehta D; Yuan JX
    Am J Physiol Cell Physiol; 2015 Apr; 308(8):C581-93. PubMed ID: 25673771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanosensitive channel Piezo1 is required for pulmonary artery smooth muscle cell proliferation.
    Chen J; Rodriguez M; Miao J; Liao J; Jain PP; Zhao M; Zhao T; Babicheva A; Wang Z; Parmisano S; Powers R; Matti M; Paquin C; Soroureddin Z; Shyy JY; Thistlethwaite PA; Makino A; Wang J; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2022 May; 322(5):L737-L760. PubMed ID: 35318857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular peroxidase 1 promotes phenotypic transformation of pulmonary artery smooth muscle cells via ERK pathway in hypoxia-induced pulmonary hypertensive rats.
    Li T; Liu B; Li NS; Luo XJ; Peng JW; Peng J
    Life Sci; 2022 Oct; 307():120910. PubMed ID: 36029851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
    Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
    Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxyl terminus of Hsc70-interacting protein (CHIP) promotes pulmonary artery smooth muscle cell (PASMC) proliferation
    Dong F; Zhang J
    Exp Lung Res; 2020 Nov; 46(9):332-340. PubMed ID: 32873086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of EZH2 on pulmonary artery smooth muscle cell migration in pulmonary hypertension.
    Wang Y; Huang XX; Leng D; Li JF; Liang Y; Jiang T
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
    Zhang MF; Liu XR; Yang N; Lin MJ
    Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble JAGGED1 inhibits pulmonary hypertension by attenuating notch signaling.
    Xiao Y; Gong D; Wang W
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2733-9. PubMed ID: 24072692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STARS knockout attenuates hypoxia-induced pulmonary arterial hypertension by suppressing pulmonary arterial smooth muscle cell proliferation.
    Shi Z; Wu H; Luo J; Sun X
    Biomed Pharmacother; 2017 Mar; 87():397-404. PubMed ID: 28068629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib alleviates experimental pulmonary hypertension by regulating intracellular calcium homeostasis in PASMCs.
    Zhang J; Lu W; Chen Y; Jiang Q; Yang K; Li M; Wang Z; Duan X; Xu L; Tang H; Sun D; Wang J
    Am J Physiol Cell Physiol; 2016 Sep; 311(3):C482-97. PubMed ID: 27413173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model.
    Pak O; Sommer N; Hoeres T; Bakr A; Waisbrod S; Sydykov A; Haag D; Esfandiary A; Kojonazarov B; Veit F; Fuchs B; Weisel FC; Hecker M; Schermuly RT; Grimminger F; Ghofrani HA; Seeger W; Weissmann N
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):358-67. PubMed ID: 23590303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Notch signaling by short-term treatment with Jagged-1 enhances store-operated Ca(2+) entry in human pulmonary arterial smooth muscle cells.
    Yamamura H; Yamamura A; Ko EA; Pohl NM; Smith KA; Zeifman A; Powell FL; Thistlethwaite PA; Yuan JX
    Am J Physiol Cell Physiol; 2014 May; 306(9):C871-8. PubMed ID: 24573085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
    J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch Activation of Ca(2+) Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary Hypertension.
    Smith KA; Voiriot G; Tang H; Fraidenburg DR; Song S; Yamamura H; Yamamura A; Guo Q; Wan J; Pohl NM; Tauseef M; Bodmer R; Ocorr K; Thistlethwaite PA; Haddad GG; Powell FL; Makino A; Mehta D; Yuan JX
    Am J Respir Cell Mol Biol; 2015 Sep; 53(3):355-67. PubMed ID: 25569851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.